Critical Survey: Anteris Technologies Global (AVR) and Its Competitors

Anteris Technologies Global (NASDAQ:AVR) is one of 142 publicly-traded companies in the “MED INSTRUMENTS” industry, but how does it compare to its competitors? We will compare Anteris Technologies Global to similar companies based on the strength of its dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

Insider and Institutional Ownership

54.1% of shares of all “MED INSTRUMENTS” companies are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 14.1% of shares of all “MED INSTRUMENTS” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Anteris Technologies Global and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Anteris Technologies Global	$2.70 million	-$76.29 million	-2.95
Anteris Technologies Global Competitors	$1.75 billion	$196.07 million	5.50

Anteris Technologies Global’s competitors have higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Anteris Technologies Global and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1	0	4	0	2.60
Anteris Technologies Global Competitors	1207	3818	7153	271	2.52

Anteris Technologies Global presently has a consensus target price of $16.50, suggesting a potential upside of 370.09%. As a group, “MED INSTRUMENTS” companies have a potential upside of 22.95%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Anteris Technologies Global is more favorable than its competitors.

Profitability

This table compares Anteris Technologies Global and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-3,944.93%	-252.71%	-169.61%
Anteris Technologies Global Competitors	-85.47%	-113.49%	-22.73%

Summary

Anteris Technologies Global competitors beat Anteris Technologies Global on 9 of the 12 factors compared.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.